News and Publications

International Journal of Radiation Oncology • Biology • Physics (Red Journal)

Red Journal Editor-in-Chief Position Opening

ASTRO is seeking an individual with strong editorial standards and leadership skills to serve a five-year term as Editor-in-Chief of the International Journal of Radiation Oncology • Biology • Physics. Please see the full position posting for more information.

The Red Journal also has a number of collections to appeal to the radiation oncology team worldwide. Our Around the Globe series looks at the how the practice of radiation oncology is different around the world based on reimbursement and culture challenges. The Oncology Scan feature looks at the vast landscape of oncology literature and summarizes what's happening in certain areas. For example, one Oncology Scan looks at quality of life for early-stage lung cancer using surgery and stereotactic body radiation therapy (SBRT) while another looks at the role of the human papillomavirus (HPV) in head and neck cancersCritical reviews are also segmented out for readers interested in this excellent over views of recent topics. Last but certainly not least is the excellent contributions of artists in radiation oncology whose artwork have graced the cover of the journal.

View a collection of the last five years of artwork.

redj_coverLed by Editor-in-Chief Anthony L. Zietman, MD, FASTRO, of Massachusetts General Hospital and Harvard University in Boston, the Red Journal is the leading journal dedicated to radiation oncology and the official scientific publication of ASTRO.

Published 15 times per year, both online and in print, the Red Journal offers authoritative articles linking new research and technologies to clinical applications. Technical advances related to dosimetry and conformal radiation treatment planning are also part of the journal. A Red Journal subscription is included in the dues for all Active, Affiliate, Allied and International members.

Submit a manuscript online.
View the instructions for authors.
Access your subscription.

Note to Authors: The Red Journal typically accepts the following types of papers.

  • High impact, original, prospective clinical trials
  • Outcomes research
  • Large database interrogation
  • Imaging and treatment delivery innovations
  • Laboratory studies on tumor physiology, molecular biology, and normal tissue radiation response
  • Critical reviews on timely topics
  • Health policy contributions
  • High impact innovations in treatment, dosimetry, and quality
  • Professionalism, biomedical ethics and practice management 
  • Educational innovation